Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBoston Scientific Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 16 | $0.65 | $0.70 | $0.67 |
| Q2 2025 | 8 | $0.70 | $0.71 | $0.71 |
| Q3 2025 | 8 | $0.71 | $0.72 | $0.71 |
| Q4 2025 | 14 | $0.76 | $0.77 | $0.77 |
| Q1 2026 | 9 | $0.75 | $0.76 | $0.76 |
| Q2 2026 | 7 | $0.80 | $0.81 | $0.81 |
| Q3 2026 | 7 | $0.81 | $0.82 | $0.82 |
| Q4 2026 | 13 | $0.86 | $0.87 | $0.87 |
| Q1 2027 | 9 | $0.83 | $0.84 | $0.83 |
| Q2 2027 | 7 | $0.86 | $0.87 | $0.87 |
| Q3 2027 | 7 | $0.93 | $0.95 | $0.94 |
| Q4 2027 | 13 | $0.96 | $0.97 | $0.97 |
Boston Scientific Corporation Earnings Date And Information
Boston Scientific Corporation last posted its earnings results on Wednesday, February 5th, 2025. The company reported $0.7 earnings per share for the quarter, topping analysts' consensus estimates of $0.657 by $0.043. The company had revenue of 4.56 B for the quarter and had revenue of 16.75 B for the year. Boston Scientific Corporation has generated $1 earnings per share over the last year ($1.25 diluted earnings per share) and currently has a price-to-earnings ratio of 76.72. Boston Scientific Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based on prior year's report dates.
Boston Scientific Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/18/2025 | Q4 2024 | N/A | $0.38 | N/A | $4.42 B | $4.56 B |
| 11/01/2024 | Q3 2024 | N/A | $0.32 | N/A | $4.04 B | $4.21 B |
| 08/01/2024 | Q2 2024 | N/A | $0.22 | N/A | $4.03 B | $4.12 B |
| 05/01/2024 | Q1 2024 | N/A | $0.34 | N/A | N/A | $3.86 B |
| 02/21/2024 | Q4 2023 | N/A | $0.34 | N/A | $3.59 B | $3.73 B |
| 11/01/2023 | Q3 2023 | N/A | $0.34 | N/A | $3.48 B | $3.53 B |
| 08/03/2023 | Q2 2023 | N/A | $0.18 | N/A | $3.50 B | $3.60 B |
| 05/04/2023 | Q1 2023 | N/A | $0.21 | N/A | N/A | $3.39 B |
| 02/23/2023 | Q4 2022 | N/A | $0.09 | N/A | N/A | $3.24 B |
| 11/03/2022 | Q3 2022 | N/A | $0.12 | N/A | $3.14 B | $3.17 B |
| 08/04/2022 | Q2 2022 | N/A | $0.17 | N/A | $3.22 B | $3.24 B |
| 05/05/2022 | Q1 2022 | N/A | $0.07 | N/A | N/A | $3.03 B |
| 02/23/2022 | Q4 2021 | N/A | $0.07 | N/A | N/A | $3.13 B |
| 11/04/2021 | Q3 2021 | N/A | $0.29 | N/A | $2.96 B | $2.93 B |
| 08/06/2021 | Q2 2021 | N/A | $0.13 | N/A | $2.94 B | $3.08 B |
| 05/06/2021 | Q1 2021 | N/A | $0.24 | N/A | N/A | $2.75 B |
| 02/23/2021 | Q4 2020 | N/A | $0.11 | N/A | N/A | $2.71 B |
| 11/05/2020 | Q3 2020 | N/A | -$0.11 | N/A | $2.52 B | $2.66 B |
| 08/05/2020 | Q2 2020 | N/A | -$0.11 | N/A | $1.73 B | $2.00 B |
| 05/06/2020 | Q1 2020 | N/A | $0.01 | N/A | N/A | $2.54 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Boston Scientific Corporation Earnings: FAQ's
Boston Scientific Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based offlast year's report dates.
In the previous quarter, Boston Scientific Corporation (:BSX) reported $0.7 earnings per share (EPS) to beat the analysts' consensus estimate of $0.657 by $0.043.
The conference call for Boston Scientific Corporation's latest earnings report can be listened to online.
The conference call transcript for Boston Scientific Corporation's latest earnings report can be read online.
Boston Scientific Corporation (:BSX) has a recorded annual revenue of $16.75 B.
Boston Scientific Corporation (:BSX) has a recorded net income of $1.85 B.Boston Scientific Corporation has generated $1.26 earnings per share over the last four quarters.
Boston Scientific Corporation (:BSX) has a price-to-earnings ratio of 76.72 and price/earnings-to-growth ratio is 23.4.